Coronavirus (COVID-19): visiting The Royal Marsden suspended

Coronavirus (COVID-19) latest: Visiting The Royal Marsden is still suspended, but we want to reassure our patients, their families and anyone worried about cancer during this difficult time that we are still delivering treatment - the hospital is open. Please see more information here about how we are keeping everyone safe.

Myeloma

The Royal Marsden offers a range of myeloma treatment and care services for patients at its hospitals in Chelsea, London, and Sutton, Surrey.

Myeloma services at The Royal Marsden

  • Diagnosis, tests and investigations: primary assessment and diagnosis in partnership with other hospitals
  • Cancer genetics
  • Chemotherapy
  • Radiotherapy
  • Stem cell transplant, total body irradiation
  • Critical care
  • Rehabilitation, including a pre-transplant programme
  • Palliative and supportive care

Services are provided through a specialised inpatient unit for the delivery of more intensive chemotherapy and a newly refurbished outpatient area

Primary assessment and diagnosis

  • Full blood count
  • Biochemistry
  • Immunoglobulins testing
  • Paraprotein testing
  • Serum free light chain measurement
  • Bone marrow estimation
  • Skeletal surveys
  • MRI
  • PET CT
  • Bone marrow genetics
  • FISH (fluorescence in situ hybridisation)
  • Cytogenetics
  • Novel prognostic markers

Treatment

  • Stem cell transplants (autologous and allogeneic donor transplants)
  • Chemotherapy using drugs such as Thalidomide, Velcade and Revlimid
  • Intensive strategies for aggressive disease
  • Access to novel drugs and clinical trials

Patient care and support

  • Clinical nurse specialist in myeloma
  • Specialist transplant nurses
  • Pain control
  • Orthopaedic and renal links